Peres Jepchirchir Provisionally Suspended After Positive EPO Test, Sydney Marathon Victory Under Scrutiny

Kenyan marathon star Peres Jepchirchir has reached a critical point in her career after the Athletics Integrity Unit (AIU) provisionally suspended her following an adverse analytical finding for erythropoietin (EPO). The 33-year-old Olympic and world marathon champion provided the out-of-competition sample in Kenya before winning the Sydney Marathon on August 30, 2026. She subsequently clocked 2:18:31, finishing more than three minutes ahead of compatriot Irine Cheptai. The case has raised serious questions about anti-doping controls in elite distance running, particularly because the sample was collected before one of the biggest victories of Jepchirchir's career.

The timing of the sample is central to the case. It was not collected during the Sydney race or immediately after she crossed the finish line. Instead, it was an out-of-competition sample collected in Kenya during the period leading up to the Australian event. This means the investigation concerns the athlete's biological profile outside competition and highlights the importance of testing throughout the training cycle rather than relying exclusively on samples collected at major championships.

The Sydney victory and the suspension

Jepchirchir delivered a commanding performance in the women's race at the Sydney Marathon on August 30, 2026. Her winning time of 2:18:31 placed her more than three minutes ahead of second-placed Kenyan runner Irine Cheptai. The victory added another major title to a career that had already included triumphs in New York, Boston and London.

On October 23, 2026, Sydney Marathon organisers issued a statement expressing disappointment after learning that Jepchirchir had been provisionally suspended by the AIU. The organisers confirmed that an out-of-competition sample collected in Kenya before the race had returned an adverse analytical finding for EPO. They also stressed that Jepchirchir was entitled to due process and said they would make no further comment until the disciplinary process had concluded.

The development is particularly significant because Sydney became the seventh Abbott World Marathon Major in 2026. Its elevation strengthened the event's international standing and increased the importance of its results within elite road running. A doping case involving the women's champion therefore affects discussions about competitive fairness, the credibility of race results and the achievements of the other athletes in the field.

Why EPO matters in marathon running

Erythropoietin, commonly known as EPO, is a hormone naturally produced primarily by the kidneys. It stimulates the bone marrow to produce red blood cells. These cells contain haemoglobin, which transports oxygen from the lungs to working muscles. Oxygen delivery is particularly important in marathon running, where athletes must sustain a demanding pace over 42.195 kilometres.

Artificial EPO can increase red blood cell production and improve the blood's oxygen-carrying capacity. This can potentially enhance aerobic endurance and an athlete's ability to maintain a high intensity over long distances. For that reason, EPO is prohibited under anti-doping regulations. Its misuse also carries serious medical risks. Excessive red blood cell production can make blood thicker, increasing the possibility of blood clots, strokes and cardiovascular complications.

Detecting EPO presents challenges for anti-doping authorities because the relationship between use, sample collection and detection can be time-sensitive. Out-of-competition testing is therefore an essential part of the anti-doping system. Jepchirchir's case demonstrates why testing outside major events matters: a sample collected during preparation can become central to an investigation even after an athlete has achieved a major competitive victory.

A career built on major international achievements

Jepchirchir has been one of the leading figures in women's distance running for several years. She won Olympic women's marathon gold at the Tokyo Games in 2026, which had originally been scheduled for 2026 before being postponed because of the COVID-19 pandemic. In September 2026, she returned to Tokyo to win the women's marathon title at the World Athletics Championships.

Her achievements extend beyond the marathon. She broke the women's half-marathon world record in 2026 and improved it on three occasions in 2026. Those performances demonstrated her ability to compete at the highest level across different road-running distances.

Her World Marathon Major victories further established her reputation. She won the New York City Marathon in 2026, the Boston Marathon in 2026 and the London Marathon in 2026 before adding Sydney in 2026. These victories placed her among the most successful women marathon runners of her generation. The EPO finding therefore has implications far beyond one race result.

Marathon success is built over years through training, altitude preparation, nutrition, recovery and careful race management. Kenya's high-altitude training culture has produced generations of world-class distance runners, and Jepchirchir's career developed within that tradition. However, when an adverse analytical finding involves an established champion, the credibility of the athlete's competitive record and the systems supporting elite preparation inevitably come under scrutiny.

A provisional suspension is not a final finding

It is important to distinguish between a provisional suspension and a final anti-doping ruling. The AIU's action prevents Jepchirchir from competing while the case proceeds through the relevant disciplinary process. It does not, by itself, establish that she has committed an anti-doping rule violation intentionally or that a final sanction has been imposed.

The athlete is entitled to respond to the allegation and use the procedures available under the applicable anti-doping rules. The evidence, laboratory processes and any explanation submitted by the athlete must be considered before a final determination is made. Consequently, it would be premature to declare Jepchirchir guilty or to assume that her Sydney victory has automatically been annulled.

Her agent, Gianni Demadonna, expressed regret in a statement, saying he felt terrible about what had happened and that athletes who use performance-enhancing drugs should be disqualified. His comments underline the seriousness of the situation but do not replace the formal disciplinary process.

The potential consequences under World Marathon Majors rules are also significant. According to the Sydney organisers' statement, an athlete who receives a ban of three months or longer for a doping offence can face a lifetime ban from all eight World Marathon Majors events. However, that consequence depends on a final finding and the sanction imposed. A provisional suspension alone does not activate the lifetime ban.

The wider challenge facing Kenyan athletics

Kenya has long been one of the dominant forces in international distance running. Its training culture, high-altitude environments and deep pool of endurance talent have produced numerous Olympic champions and world record holders. Yet a succession of doping cases involving Kenyan athletes has placed the country's reputation under pressure.

Addressing the problem requires more than increasing the number of bans. Athletes need better education about prohibited substances, unregulated medical treatments and supplement contamination. Coaches, medical personnel and athlete support teams must also be held accountable. Without transparency throughout the training and medical support system, increasing testing only at major competitions will not provide a lasting solution.

The case also has implications for competitors such as Irine Cheptai, who finished second in Sydney. Fair competition involves recognising the years of preparation and sacrifice made by every athlete who follows the rules. The integrity of a result matters to the entire field, not merely to the winner.

The investigation will determine what comes next

The next stage will depend on the AIU's disciplinary proceedings, the evidence surrounding the sample and Jepchirchir's response. Until the process is complete, the case must be treated as an unresolved anti-doping matter rather than a final judgment on her career.

Based on my years of watching athletics and covering multi-sport events, the stopwatch records a performance, but the credibility of that performance depends on the system operating before and after the finish line. Jepchirchir's 2:18:31 remains the recorded Sydney winning time at this stage. The coming months will determine the implications for her career and the status of that achievement. More broadly, the case will test whether international athletics can protect clean competition consistently, including during the long training periods when the foundations of marathon victories are laid.